Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Asiafocus Regulatory News (AAS)

Share Price Information for Abrdn Asiafocus (AAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 280.00
Bid: 279.00
Ask: 282.00
Change: 1.00 (0.36%)
Spread: 3.00 (1.075%)
Open: 277.00
High: 283.00
Low: 277.00
Prev. Close: 279.00
AAS Live PriceLast checked at -
abrdn Asia Focus is an Investment Trust

To maximise long-term total return from a portfolio made up predominantly of smaller quoted companies (with a market cap of up to approximately USD 1.5bn at the time of investment) in the economies of Asia and Australasia, ex Japan.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

31 Oct 2019 16:20

RNS Number : 8710R
Aberdeen Standard Asia Focus PLC
31 October 2019
 

ABERDEEN STANDARD ASIA FOCUS PLC

Legal Entity Identifier (LEI): 5493000FBZP1J92OQY70

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Aberdeen Standard Asia Focus Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Horizontal Aggregation Disclosure

X

3. Details of person subject to the notification obligationiv

Name

Brewin Dolphin Ltd

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

29 October 2019

6. Date on which issuer notified (DD/MM/YYYY):

31/10/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

2.3236%

N/A

2.3236%

36,046,207

Position of previous notification (if

applicable)

2.3329%

N/A

2.3329%

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD 0.25

GB0000100767

N/A

408,574

N/A

1.2187%

2.25% CNV 31/05/2025 GBP GB00BFZ0WT29

N/A

428,989

N/A

17.0109%

SUBTOTAL 8. A

837,563

2.3236%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

ORD 25p

Indirect - Brewin Nominees Limited A/c NOM

0.9867%

N/A

0.9867%

Indirect - Brewin Nominees Limited A/c ISA

0.0983%

N/A

0.0983%

Indirect - Brewin Nominees Limited A/c GROSS

0.0591%

N/A

0.0591%

Indirect - Brewin Nominees Limited A/c CHARITY

0.0653%

N/A

0.0653%

Indirect - Brewin Nominees Limited A/c OFFBOND

0.0093%

N/A

0.0093%

TOTAL

1.2187%

2.25% CNV 2025

Indirect - Brewin Nominees (Channel Islands) Limited - JPAL

0.1354%

N/A

0.1354%

Indirect - Brewin Nominees Limited A/c NOM

4.4835%

N/A

4.4835%

Indirect - Brewin Nominees Limited A/c ISA

6.6974%

N/A

6.6974%

Indirect - Brewin Nominees Limited A/c GROSS

5.6246%

N/A

5.6246%

Indirect - Brewin Nominees Limited A/c CHARITY

0.0678%

N/A

0.0678%

Indirect - Brewin Nominees Limited A/c OFFBOND

0.0022%

N/A

0.0022%

TOTAL

17.0109%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Figures based on the total amalgamated potential Voting Rights that would be in issue in the scenario of all CULS converted @ 36,046,207

Voting rights in issue of 33,524,349 ORD, 36,945,232 @ Conversion Price 14.65 = 2,521,858 2025 CULS.

Disclosure due to the individual horizontal aggregation holding for the 2025 CULS line crossing the 17% reportable threshold.

 

The indirect voting rights under (9) relate to shares held in client portfolios, managed by those firms, under discretionary investment management agreements.

 

Place of completion

Newcastle upon Tyne

Date of completion

31 October 2019

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUAANRKKAROAA
Date   Source Headline
19th Mar 202412:24 pmRNSNet Asset Value(s)
18th Mar 20242:19 pmRNSGearing Disclosure
18th Mar 202411:46 amRNSNet Asset Value(s)
15th Mar 20245:11 pmRNSTransaction in Own Shares
15th Mar 202412:22 pmRNSNet Asset Value(s)
14th Mar 20243:46 pmRNSPortfolio disclosure
14th Mar 202411:39 amRNSNet Asset Value(s)
13th Mar 202411:34 amRNSNet Asset Value(s)
12th Mar 20245:07 pmRNSTransaction in Own Shares
12th Mar 202412:20 pmRNSNet Asset Value(s)
11th Mar 20242:27 pmRNSGearing disclosure
11th Mar 202412:28 pmRNSNet Asset Value(s)
8th Mar 202412:36 pmRNSNet Asset Value(s)
7th Mar 20245:12 pmRNSTransaction in Own Shares
7th Mar 202412:36 pmRNSNet Asset Value(s)
6th Mar 20245:25 pmRNSMonth End Net Asset Value(s)
6th Mar 202411:46 amRNSNet Asset Value(s)
5th Mar 20245:19 pmRNSTransaction in Own Shares
5th Mar 202412:41 pmRNSNet Asset Value(s)
4th Mar 20245:13 pmRNSTransaction in Own Shares
4th Mar 20242:18 pmRNSGearing disclosure
4th Mar 202412:13 pmRNSNet Asset Value(s)
1st Mar 20245:37 pmRNSTransaction in Own Shares
1st Mar 202410:41 amRNSTotal Voting Rights
1st Mar 202410:38 amRNSAppointment of New Director
29th Feb 202412:55 pmRNSNet Asset Value(s)
28th Feb 202411:33 amRNSNet Asset Value(s)
27th Feb 20245:26 pmRNSTransaction in Own Shares
27th Feb 202412:46 pmRNSNet Asset Value(s)
26th Feb 20245:36 pmRNSGearing Disclosures
26th Feb 20245:10 pmRNSTransaction in Own Shares
26th Feb 20241:50 pmRNSNet Asset Value(s)
23rd Feb 202412:21 pmRNSNet Asset Value(s)
22nd Feb 202412:52 pmRNSNet Asset Value(s)
21st Feb 20245:31 pmRNSTransaction in Own Shares
21st Feb 20242:00 pmRNSCompliance with Market Abuse Regulation
21st Feb 202412:48 pmRNSNet Asset Value(s)
20th Feb 20245:26 pmRNSTransaction in Own Shares
20th Feb 20243:14 pmRNSDirector/PDMR Shareholding
20th Feb 202412:36 pmRNSNet Asset Value(s)
19th Feb 202412:50 pmRNSGearing disclosure
19th Feb 202411:56 amRNSNet Asset Value(s)
16th Feb 20245:11 pmRNSTransaction in Own Shares
16th Feb 202412:35 pmRNSNet Asset Value(s)
15th Feb 20245:17 pmRNSTransaction in Own Shares
15th Feb 202411:06 amRNSNet Asset Value(s)
14th Feb 20245:20 pmRNSTransaction in Own Shares
14th Feb 20241:04 pmRNSNet Asset Value(s)
14th Feb 202410:41 amRNSPortfolio Disclosures
14th Feb 202410:35 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.